Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

Bill: 116-hr-269
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
Introduced: 2019-01-08 in the House
Policy area: Health
Subjects: Administrative law and regulatory procedures
Advanced technology and technological innovations
Advisory bodies
Aging
Blood and blood diseases
Border security and unlawful immigration
Centers for Disease Control and Prevention (CDC)
Chemical and biological weapons
Child health
Child safety and welfare
Computer security and identity theft
Congressional oversight
Consumer affairs
Disability and paralysis
Disaster relief and insurance
Drug safety, medical device, and laboratory regulation
Emergency communications systems
Emergency medical services and trauma care
Emergency planning and evacuation
Environmental health
First responders and emergency personnel
Food and Drug Administration (FDA)
General health and health care finance matters
Genetics
Government employee pay, benefits, personnel management
Government information and archives
Government liability
Hazardous wastes and toxic substances
Health facilities and institutions
Health information and medical records
Health personnel
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Homeland security
Hospital care
Immunology and vaccination
Infectious and parasitic diseases
Infrastructure development
Intelligence activities, surveillance, classified information
Intergovernmental relations
Judicial review and appeals
Licensing and registrations
Marketing and advertising
Medical research
Military medicine
Minority health
Musculoskeletal and skin diseases
Natural disasters
Performance measurement
Prescription drugs
Research and development
Social work, volunteer service, charitable organizations
State and local government operations
Technology assessment
Terrorism
User charges and fees
Veterinary medicine and animal diseases
Women's health
World health

Summary:
action_date: 2019-01-08
text: 

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

 
This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs.
 
Among other programs, the bill reauthorizes through FY2023 and revises
 
 
the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), 
 
the Hospital Preparedness Program, 
 
the CDC situational-awareness and biosurveillance program, 
 
the Emergency System for Advance Registration of Volunteer Health Professionals, 
 
the National Disaster Medical System, 
 
the Volunteer Medical Reserve Corps, 
 
the National Advisory Committee on Children and Disasters, 
 
the Strategic National Stockpile, and 
 
the Biomedical Advanced Research and Development Authority. 

 
In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams.
 
The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.

action_date: 2019-01-08
text: 

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

 
This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs.
 
Among other programs, the bill reauthorizes through FY2023 and revises
 
 
the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), 
 
the Hospital Preparedness Program, 
 
the CDC situational-awareness and biosurveillance program, 
 
the Emergency System for Advance Registration of Volunteer Health Professionals, 
 
the National Disaster Medical System, 
 
the Volunteer Medical Reserve Corps, 
 
the National Advisory Committee on Children and Disasters, 
 
the Strategic National Stockpile, and 
 
the Biomedical Advanced Research and Development Authority. 

 
In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams.
 
The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.


Legislative actions:
action_date: 2019-01-10
text: Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
action_date: 2019-01-09
text: Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
action_date: 2019-01-08
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2019-01-08
text: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
action_date: 2019-01-08
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13).(text: CR H237-262)
action_date: 2019-01-08
text: Considered as unfinished business. (consideration: CR H275-276)
action_date: 2019-01-08
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2019-01-08
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 269.
action_date: 2019-01-08
text: Considered under suspension of the rules. (consideration: CR H237-266)
action_date: 2019-01-08
text: Mr. Pallone moved to suspend the rules and pass the bill.
action_date: 2019-01-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-01-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-01-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-01-08
text: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2019-01-08
text: Introduced in House
action_date: 2019-01-08
text: Introduced in House